DEFERASIROX

Formula & Concentration

DEFERASIROX – deferasirox 250 mg dispersible tablet

Manufacturer

Sun Pharmaceutical Industries, Inc.

Indications

Chronic iron overload in NTD thalassemia; chronic iron overload due to repeated blood transfusions

Product Options

Package Size

NDC #

Presentation

250 mg

62756-0569-83

Tab Disper

500 mg

62756-0570-83

Tab Disper

Shelf Life and Storage

Controlled Room Temp (20-25°C)